期刊文献+

磷脂酶A2受体与特发性膜性肾病 被引量:14

Phospholipase A2 receptor in idiopathic membranous nephropathy
暂未订购
导出
摘要 特发性膜性肾病(IMN)是一种以肾小球毛细血管袢上皮侧免疫复合物沉积为特征的肾小球疾病,其致病抗体抗M型磷脂酶A2受体1(PLA2R1)抗体的发现使得IMN的诊断、预后判断和病情监测等方面取得突破性的进展。全基因组关联研究发现HLA-DQA1和PLA2R1是IMN的易感基因,进一步明确IMN的遗传学背景。最近研究发现PLA2R上引发免疫反应的主要抗原表位。本文就PLA2R与IMN的研究进展作一综述。 Idiopathic membranous nephropathy (IMN)is a glomerulopathy characterized by immune complex deposit on the epithelial side of glomerular capillary wall with elusive etiology.The discovery of serum anti-PLA2R antibody was a landmark breakthrough in the understanding of IMN pathogenesis and made great contribution to IMN diagnosis, prognosis prediction and disease activity surveillance. GWAS study found SNP in HLA-DQA1 and PLA2R1 gene locus related to susceptibility of IMN, indicating a genetic background of IMN.Recent study has also identified dominant epitope of PLA2R.This review focused on the main discoveries and current knowledge of PLA2R and IMN.
出处 《肾脏病与透析肾移植杂志》 CSCD 北大核心 2015年第2期165-170,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家科技支撑计划课题(2013BAI09B04)(2015BAI12B05) 江苏省临床医学中心项目(BL2012007)
关键词 膜性肾病 特发性 磷脂酶A2受体 membranous nephropathy idiopathic phospholipase A2 receptor
  • 相关文献

参考文献32

  • 1Ronco P, Debiec H. Pathogenesis of membranous nephropathy : recent advances and future challenges. Nat Rev Nephrel, 2012, 8 ( 4 ) : 203-213.
  • 2Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med, 2009,361 ( 1 ) : 11-21.
  • 3Stanescu HC,Arcos-Burgos M, Medlar A, et al.Risk HLA-DQA1 and PLA(2) R1 alleles in idiopathic membranous nephropathy. N Engl J Med,2011,364(7) :616-626.
  • 4Lv J,Hou W,Zhou X,et al.Interaction between PLA2R1 and HLA- DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. J Am Soc Nephrol, 2013, 24 (8): 1323-1329.
  • 5Hofstra JM, Beck LH Jr, Beck DM, et al. Anti-phospholipase A ( 2 ) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol, 2011, 6 ( 6 ) : 1286-1291.
  • 6Qin W, Beck LH Jr, Zeng C, et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol, 2011,22 (6) :1137-1143.
  • 7Svobodova B, Honsova E, Ronco P, et al.Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol Dial Transplant, 2013,28 ( 7 ) : 1839-1844.
  • 8Schlumberger W, Hornig N, Lange S, et al. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.Autoimmun Rev, 2014,13 (2) : 108-113.
  • 9Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy.N Engl J Med, 2011,364 (7) : 689-690.
  • 10Hoxha E, Harendza S, Zahner G, et al.An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant,2011,26(8) :2526-2532.

同被引文献87

  • 1王永钧,陈洪宇.IgA肾病中西医结合诊断及治疗建议[J].中国中西医结合肾病杂志,2005,6(2):63-66. 被引量:25
  • 2马序竹,张宏,王素霞,邹万忠,王海燕.IgA肾病合并原发性膜性肾病二例并文献复习[J].中华内科杂志,2006,45(6):472-474. 被引量:14
  • 3王素霞,邹万忠,杨莉,赵明辉.膜性肾病合并IgA肾病的临床病理特点[J].中华病理学杂志,2007,36(3):171-174. 被引量:25
  • 4Doi T, Kanatsu K, Nagai H, et al. An over lapping syndrome of IgA nephropathy and membranous nephr opathy? Nephron, 1983,35(1) :24-30.
  • 5Stokes MB, Alpers CE. Combined membranous nephropathy and IgA nephropathy. Am J Kidney Dis, 1998,32 (4) :649 - 656.
  • 6Jennette JC, Newman WJ, Diaz - Buxo JA. Overlapping IgA and membranous nephropathy. Am J Clin Pathol, 1987,88 (1):74- 78.
  • 7宋岩,李冀军,张壹言,等.原发性膜性肾病合并IgA肾病二例的临床病理特点及文献复习.中华临床医师杂志(电子版),2013,(24):11436-11440.
  • 8RiYang L, HangYing Y, JunYan Q, et al. Association between tongue coating thickness and clinical characteristics among idio- pathic membranous nephropathypatients[J]. J Ethnopharmacol, 2015, 71(2) : 125 -130.
  • 9Chert Y, Dang Y, Ni Z, et al. Efficacy and safety of traditional Chinese medicine (Shenqi particle ) for patients with idiopathic membranous nephropathy: a Muhicenter randomized controlled clinical trial[J]. Am J Kidney Dis, 2013, 62(6) : 1068 - 1076.
  • 10Naumovic R, Jovanovic D, Pavlovic S, et al. Cyclosporine versus azathioprine therapy in high -risk idiopathicmembranous nephrop- athy patients : A 3 - year prospective study [J]. Biomed Pharma- cother, 2011, 65(2): 105-110.

引证文献14

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部